Form D · Other Health Care
Texas Medical Toxicology, LLC
Houston, TX · CIK 0001557706
Offering snapshot reported Sep 12, 2012 · SEC filing
- Reported sold
- $141K Offering amount: $333K
- Investors reported
- 8 Form D · investor count
- Minimum accepted
- $8.32K Reported outside-investor minimum
- First sale
- Apr 12, 2012 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 12, 2012 | Initial | $141,440 | No comparison | 8 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 04, 06
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-184022
Source: Form D, filed Sep 12, 2012. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Jeffrey Charnov, M.D. | Director |
| Jason Fisher | Director |
| Scott Stoeckel | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
7707 Fannin Suite 290
Houston, TX, 77054
Houston, TX, 77054